Peptidomimetic Design of CDK Inhibitors Targeting theRecruitment Site of the Cyclin Subunit

Publisher： Bentham Science Publishers

E-ISSN： 1875-5968|3|1|57-69

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.3, Iss.1, 2003-01, pp. : 57-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Underexpression of Cyclin-Dependent Kinase (CDK) Inhibitors in Cervical Carcinoma

By Kim Y.T.   Cho N.H.   Park S.W.   Kim J.W.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 38-45

Elsevier

Access to resources Recommend Favorite

X-Ray Crystallographic Studies of CDK2, a Basis for Cyclin-Dependent Kinase Inhibitor Design in Anti-Cancer Drug Research

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 1, 2003-01 ,pp. : 15-23

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 10, 2016-08 ,pp. : 1325-1338

Bentham Science Publishers

Access to resources Recommend Favorite

Chemical and Biological Profile of Dual Cdk1 and Cdk2 Inhibitors

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 1, 2003-01 ,pp. : 1-14

Bentham Science Publishers

Access to resources Recommend Favorite

Expression and clinical significance of cyclin kinase subunit 2 in colorectal cancer

By      

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 777-780

Spandidos Publications

Access to resources Recommend Favorite